Co-Authors
This is a "connection" page, showing publications co-authored by Lorenzo Dagna and Giuseppe Ramirez.
Connection Strength
3.037
-
Systemic lupus erythematosus and COVID-19: what we know so far. Ann Rheum Dis. 2020 Aug 28.
Score: 0.900
-
Eosinophils from Physiology to Disease: A Comprehensive Review. Biomed Res Int. 2018; 2018:9095275.
Score: 0.752
-
Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort'. Ann Rheum Dis. 2021 Oct; 80(10):e159.
Score: 0.237
-
Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19. Clin Microbiol Infect. 2021 08; 27(8):1190-1192.
Score: 0.236
-
Continuous positive airway pressure and pronation outside the intensive care unit in COVID 19 ARDS. Minerva Med. 2020 Sep 30.
Score: 0.226
-
COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients. Semin Arthritis Rheum. 2020 10; 50(5):1150-1157.
Score: 0.222
-
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease. Rheumatology (Oxford). 2017 12 01; 56(12):2084-2092.
Score: 0.186
-
Testosterone in males with COVID-19: A 7-month cohort study. Andrology. 2022 01; 10(1):34-41.
Score: 0.060
-
Biobanking for COVID-19 research. Panminerva Med. 2020 Oct 19.
Score: 0.057
-
Colchicine treatment in community healthcare setting to prevent severe COVID-19. Ann Rheum Dis. 2020 Aug 27.
Score: 0.056
-
Treating COVID-19 with colchicine in community healthcare setting. Clin Immunol. 2020 08; 217:108490.
Score: 0.055
-
Diamine Oxidase Supplementation in Chronic Spontaneous Urticaria: A Randomized, Double-Blind Placebo-Controlled Study. Int Arch Allergy Immunol. 2018; 176(3-4):268-271.
Score: 0.048